INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KD
Keefauver DavidEVP of People
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$39K
193 sh
Jan 31, 2026Feb 2, 2026
Page 1364 of 1786
← PrevNext →
traded Jan 31, 2026
+2d
SEC Form 4

Evidence

9
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$13K
111 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
ZT
Zandhuis TerriChief People Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$2,948
933 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HR
Hasani RamiEVP, Chief Financial Officer
UWMCUWM Holdings Corp
Grant or award
A—
175.4K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$48K
416 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
WP
Wu Cheng-Sheng PeterDirector
CINFCINCINNATI FINANCIAL CORP
Grant or award
A—
847 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
207.2K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$30K
268 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HH
Harris Isaac HosojiroDirector, SEE REMARKS
LITELumentum Holdings Inc.
Grant or award
A—
629 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
RR
Ross Scott RichardEVP & CIO
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
17.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
RL
Reaves Shari LynneSVP OF HR AND TRAINING
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MA
Montellano Najera Jose ASVP OF WESTERN STORE OPS/SALES
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
NT
Nguyen Anh TuSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
162.2K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
Thomas RagyDirector
CXMSprinklr, Inc.
Derivative conversion
C—
1,054 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
KC
Kale Justin ChristopherSVP CENTRAL STORE OPS & SALES
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
CD
Conn Avi DanielChief Financial Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
10.8K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
168.5K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
ZT
Zandhuis TerriChief People Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
2,764 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
CL
Contreras Lerdo de Tejada LeonardoDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
GA
Gelfand Jeffrey AdamDirector
NONENONEPIMCO Asset-Based Lending Co LLC
Grant or award
A—
2,811 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
KE
Krohne Susan EChief Legal Officer, Secretary
MHOM/I HOMES, INC.
Option exercise
M—
5,000 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
KD
Kauh John Saewook M.D.Chief Medical Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
DR
Duvivier RaphaelChief Financial Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
1,382 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
CL
Contreras Lerdo de Tejada LeonardoDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
400 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$33K
294 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
DR
Duvivier RaphaelChief Financial Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$2,054
650 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
OP
Odems Ramon ParisesSVP NORTHEAST STORE OPS &SALES
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
GD
Gray Larry DeanSVP OF INVENTORY MANAGEMENT
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TB
Tadele BeimnetEVP & President, Restaurants
VYXNCR Voyix Corp
Option exercise
M—
4,941 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

9
LT
Loafman Jeffery ThomasSVP OF DISTRIBUTION OPERATIONS
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TC
Tarvin Landon CPresident,UFP Retail Solutions
UFPIUFP INDUSTRIES INC
Grant or award
A$1,136
11 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
AN
Alibhai Imran NizamudinDirector, Chief Executive Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
115.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

8
FF
Flannery FionaDirector
GFNEW GERMANY FUND INC
Other acquisition or disposition
J$113
9 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

8
MW
Magnuson WilliamDirector, Chief Executive Officer
BRZEBraze, Inc.
Other acquisition or disposition
J—
51.7K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

8
WS
Wiseman SusanGeneral Counsel
BRZEBraze, Inc.
Other acquisition or disposition
J—
26.4K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

8
WI
Winkles IsabelleChief Financial Officer
BRZEBraze, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

8
HH
Harris Isaac HosojiroDirector, SEE REMARKS
LITELumentum Holdings Inc.
Tax withholding
F$88K
225 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

8
WB
Webb BrianEVP- Final Mile Services
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$53K
262 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$201K
27.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence